Generic Drug Office’s Policy Staff Returning To US FDA

 
• By Derrick Gingery
  
The FDA now has reversed cuts of several medical product policy groups. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Generics

More from Approval Standards